Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment
暂无分享,去创建一个
Jan Sijbers | Ines Blockx | Marleen Verhoye | Johan Van Audekerke | Annemie Van der Linden | Geert De Groof | Kerstin Raber | Dirk Poot | Alexander P. Osmand | Stephan Von Hörsten | M. Verhoye | D. Poot | I. Blockx | G. D. Groof | S. Hörsten | A. Osmand | J. Audekerke | K. Raber | A. Linden | Jan Sijbers | G. Groof
[1] J. Helpern,et al. Three‐dimensional characterization of non‐gaussian water diffusion in humans using diffusion kurtosis imaging , 2006, NMR in biomedicine.
[2] Yoram Cohen,et al. QSI and DTI of excised brains of the myelin-deficient rat , 2009, NeuroImage.
[3] J. Kordower,et al. Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements , 2004, Journal of neurocytology.
[4] Paolo Guidetti,et al. Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease , 2010, Progress in Neurobiology.
[5] Sandrine Humbert. Is Huntington disease a developmental disorder? , 2010, EMBO reports.
[6] Anil Kumar,et al. Huntington’s disease: pathogenesis to animal models , 2010, Pharmacological reports : PR.
[7] Stephan E Maier,et al. Developmental changes and injury induced disruption of the radial organization of the cortex in the immature rat brain revealed by in vivo diffusion tensor MRI. , 2007, Cerebral cortex.
[8] R H Myers,et al. Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.
[9] Sarah A. J. Reading,et al. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.
[10] P G Bhide,et al. Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.
[11] S. Floresco,et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.
[12] E. Wu,et al. MR diffusion kurtosis imaging for neural tissue characterization , 2010, NMR in biomedicine.
[13] Ryuta Ito,et al. Maturational changes in diffusion anisotropy in the rat corpus callosum: Comparison with quantitative histological evaluation , 2008, Journal of magnetic resonance imaging : JMRI.
[14] Peng Yu,et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.
[15] Hao Huang,et al. Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging , 2003, NeuroImage.
[16] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[17] Vincent A Magnotta,et al. Morphology of the cerebral cortex in preclinical Huntington's disease. , 2007, The American journal of psychiatry.
[18] M. Hayden,et al. Wild‐type huntingtin protects neurons from excitotoxicity , 2006, Journal of neurochemistry.
[19] Jan Sijbers,et al. A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease , 2012, Neurobiology of Aging.
[20] Paul M. Pilowsky,et al. Retrograde Tracing with Cholera Toxin B–Gold or with Immunocytochemically Detected Cholera Toxin B in Central Nervous System , 1992 .
[21] Kevin C. Chan,et al. Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study , 2009, NeuroImage.
[22] J. Helpern,et al. Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.
[23] Ronald Wetzel,et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.
[24] M. Solaiyappan,et al. Diffusion tensor imaging of the developing mouse brain , 2001, Magnetic resonance in medicine.
[25] M. Mehler,et al. Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat , 2000, Trends in Neurosciences.
[26] J. Thiran,et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[27] Klaus Seppi,et al. Diffusion‐weighted imaging in Huntington's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[28] P. Hüppi,et al. Diffusion tensor imaging of normal and injured developing human brain ‐ a technical review , 2002, NMR in biomedicine.
[29] P. Conn. Methods in neurosciences , 1991 .
[30] R H Myers,et al. Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.
[31] Elena Cattaneo,et al. Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.
[32] Ronald Wetzel,et al. Imaging polyglutamine deposits in brain tissue. , 2006, Methods in enzymology.
[33] A. Aron,et al. Contrasting gray and white matter changes in preclinical Huntington disease , 2010, Neurology.
[34] L. Raymond,et al. N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease , 2007, Progress in Neurobiology.
[35] Ed X. Wu,et al. Towards better MR characterization of neural tissues using directional diffusion kurtosis analysis , 2008, NeuroImage.
[36] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[37] Christian Beaulieu,et al. Diffusion tensor imaging of neurodevelopment in children and young adults , 2005, NeuroImage.
[38] Thomas Walther,et al. Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.
[39] J. Helpern,et al. Diffusion tensor imaging in fixed brain tissue at 7.0 T , 2003, NMR in biomedicine.
[40] Michael R. Hayden,et al. Mutant Huntingtin Enhances Excitotoxic Cell Death , 2001, Molecular and Cellular Neuroscience.
[41] Virginia E. Papaioannou,et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.
[42] Lili Zhou,et al. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[43] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] G. Elder,et al. Schwann cells and oligodendrocytes read distinct signals in establishing myelin sheath thickness , 2001, Journal of neuroscience research.
[45] Jean-Marie Bonny,et al. In vivo analysis of the post‐natal development of normal mouse brain by DTI , 2007, NMR in biomedicine.
[46] Jim Mintz,et al. Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.
[47] G. Bates,et al. Huntingtin and the molecular pathogenesis of Huntington's disease , 2004, EMBO reports.
[48] Ines Blockx,et al. Genotype specific age related changes in a transgenic rat model of Huntington's disease , 2011, NeuroImage.
[49] Wilhelm Gaus,et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.
[50] Andrea Ciarmiello,et al. Seeking Brain Biomarkers for Preventive Therapy in Huntington Disease , 2011, CNS neuroscience & therapeutics.
[51] Mario Mascalchi,et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.
[52] Bin Zhang,et al. Requirement of Heavy Neurofilament Subunit in the Development of Axons with Large Calibers , 1998, The Journal of cell biology.
[53] Adriana Di Martino,et al. Age‐related non‐Gaussian diffusion patterns in the prefrontal brain , 2008, Journal of magnetic resonance imaging : JMRI.
[54] D. Rice,et al. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.
[55] Anne-Catherine Bachoud-Lévi,et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.
[56] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[57] W. Le,et al. The Importance of Titrating Antibodies for Immunocytochemical Methods , 2008, Current protocols in neuroscience.
[58] Fahmeed Hyder,et al. Neurodevelopment of C57B/L6 mouse brain assessed by in vivo diffusion tensor imaging , 2007, NMR in biomedicine.
[59] Wenzhen Duan,et al. Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease , 2011, The Journal of Neuroscience.
[60] M. Johnston,et al. Quinolinate-induced injury is enhanced in developing rat brain. , 1994, Brain research. Developmental brain research.
[61] P A Narayana,et al. Early postnatal development of rat brain: In vivo diffusion tensor imaging , 2008, Journal of neuroscience research.
[62] Derek K. Jones,et al. Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002 .
[63] U. Kumar,et al. Differential expression of Huntington's disease gene (IT15) mRNA in developing rat brain. , 2004, Brain research. Molecular brain research.
[64] Jane S. Paulsen,et al. Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.
[65] G. Bernhard Landwehrmeyer,et al. IT15 gene expression in fetal human brain , 1994, Brain Research.
[66] Sarah A. J. Reading,et al. Functional brain changes in presymptomatic Huntington's disease , 2004, Annals of neurology.
[67] Richard S. J. Frackowiak,et al. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials , 2009, Neuroscience.
[68] Timothy Edward John Behrens,et al. In vivo evidence for the selective subcortical degeneration in Huntington's disease , 2009, NeuroImage.
[69] P. Basser,et al. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.
[70] C. Ross,et al. Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.
[71] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[72] G. Egan,et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.
[73] Elsdon Storey,et al. Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex , 1992, Journal of the Neurological Sciences.
[74] Jeffrey H Kordower,et al. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease , 2004, The Journal of comparative neurology.
[75] J. Olney,et al. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.